Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

3.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
3.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

2.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
2.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
T Cell Types and Functions01:24

T Cell Types and Functions

1.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358].

Critical reviews in oncology/hematology·2026
Same author

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Cancers·2026
Same author

Erratum to "Pathologists in Venice - Real world cases for an immersive training experience": Education, gaming, and show. <i>Journal of Pathology Informatics</i>, Volume 17, 2025, 100418.

Journal of pathology informatics·2026
Same author

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

Nature communications·2026
Same author

Nodular secondary syphilis in a patient who was immunocompetent: a sporotrichoid masquerader with synchronous primary lesion.

Skin health and disease·2026
Same author

Unveiling the molecular profile of adenosquamous gallbladder carcinoma: characterization of a Caucasian cohort.

Histopathology·2026
Same journal

Research advances and application prospects of CAR-T therapy in the treatment of age-related diseases.

Frontiers in immunology·2026
Same journal

Machine learning-driven identification and immunohistochemical validation of an integrated immune-inflammatory phenotype for disease-free survival stratification in breast cancer.

Frontiers in immunology·2026
Same journal

Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report.

Frontiers in immunology·2026
Same journal

Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma.

Frontiers in immunology·2026
Same journal

JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases.

Frontiers in immunology·2026
Same journal

Cross-talk among novel programmed cell death pathways: a decisive network in renal ischemia-reperfusion injury.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Aug 12, 2025

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
06:12

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro

Published on: March 7, 2022

3.5K

CK2β-regulated signaling controls B cell differentiation and function.

Laura Quotti Tubi1,2, Elisa Mandato1,2,3, Sara Canovas Nunes1,2,4

  • 1Department of Medicine, Division of Hematology, University of Padova, Padova, Italy.

Frontiers in Immunology
|January 30, 2023
PubMed
Summary
This summary is machine-generated.

The study reveals that the CK2β subunit is crucial for normal B-cell development and immune responses. Its absence impairs B-cell activation, antibody production, and affinity maturation, impacting B-cell lymphoma.

Keywords:
B cell developmentB cell receptor signalingB lymphocyteDiffuse large B cell lymphomagerminal centermarginal zoneprotein kinase CK2

More Related Videos

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
07:07

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice

Published on: June 27, 2020

5.4K
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.4K

Related Experiment Videos

Last Updated: Aug 12, 2025

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
06:12

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro

Published on: March 7, 2022

3.5K
Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
07:07

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice

Published on: June 27, 2020

5.4K
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.4K

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Serine-Threonine kinase CK2 (Casein Kinase 2) is known to support malignant B-lymphocyte growth.
  • The specific role of CK2 in normal B-cell development and activation remains largely undefined.

Purpose of the Study:

  • To investigate the function of the CK2β regulatory subunit in B-cell development and activation using a B-cell specific knockout mouse model.
  • To elucidate the impact of CK2β deficiency on B-cell signaling pathways and immune responses.

Main Methods:

  • Generation of a B-cell specific knockout mouse model for the CK2β subunit (CK2βKO).
  • Biochemical and transcriptomic analyses to assess signaling pathways and gene expression.
  • Immunization studies with sheep red blood cells (SRBC) and NP-CGG antigen.
  • In vitro assays to evaluate B-cell signaling downstream of various receptors.

Main Results:

  • CK2βKO mice showed altered B-cell populations (increased marginal zone, reduced follicular).
  • NOTCH2 pathway activation was increased, sustaining marginal zone B-cell development.
  • Impaired B-cell signaling downstream of B-cell receptor (BCR), Toll-like receptor, CD40, and IL-4R was observed.
  • Reduced antibody affinity maturation and impaired germinal center B-cell responses were noted upon immunization.
  • CK2 inactivation in diffuse large B-cell lymphoma (DLBCL) cells mimicked these signaling defects.

Conclusions:

  • The CK2β subunit plays a critical role in regulating B-cell development, particularly marginal zone B-cell populations.
  • CK2β is essential for effective B-cell activation, immune response, and antibody affinity maturation.
  • Targeting CK2 may offer a therapeutic strategy for B-cell malignancies like DLBCL by disrupting essential signaling pathways.